Safety study of the EAS1 system for small lung tumors
Part of Cancer, Lungs & breathing clinical trials.
This study tests a new system called EAS1 for people with early-stage lung cancer who are already scheduled for surgery. The goal is to see if the device is safe and works well, and it may offer a less invasive way to remove small lung tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have early-stage lung cancer (cT1a-T1c, cN0) with a tumor that is 30 mm or smaller.
- You are scheduled for or eligible for surgery to remove the lung tumor.
- Your lungs are healthy enough for surgery (tests like breathing function and oxygen levels are within certain limits).
- You are not taking blood thinners that cannot be stopped before the procedure, and you do not have other major health issues that would make the study unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new surgical robot that uses only one small opening in the chest to remove a lung segment or lobe. It aims to see if the robot is safe and effective for patients who need this type of surgery.
This trial tests whether a special navigation system during lung cancer surgery (using SERS technology) can help surgeons better locate and remove lung tumor tissue. You may be able to take part if you are having surgery to remove the tumor and meet the study’s timing and health requirements.
This trial tests a new way to treat small lung cancers using a special tool during bronchoscopy (a scope down the windpipe). The goal is to see if the ablation (heat treatment) works well before the tumor is surgically removed.
This trial looks at using a scope with an ultrasound tip (EBUS-TBNA) to take small tissue samples from lymph nodes to figure out the cancer stage before stereotactic body radiotherapy (SBRT). The goal is to help confirm how far the cancer has spread so SBRT can be planned appropriately.
This trial is looking at how well a lung cancer treatment improves survival. It enrolls adults with confirmed lung cancer who can safely take the study medicines and have cancer that can be measured on scans.
This trial tests a new treatment that uses short electrical pulses (pulsed electric field ablation) to destroy small lung tumors. It may be an option for people with limited, early-stage non-small cell lung cancer who can tolerate a minimally invasive procedure.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.